Verve Therapeutics Inc
NASDAQ:VERV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Verve Therapeutics Inc
NASDAQ:VERV
|
US |
|
WuXi Biologics (Cayman) Inc
F:1FW1
|
CN |
|
Primerica Inc
NYSE:PRI
|
US |
|
F
|
FutureFuel Corp
SWB:3FF
|
US |
|
L
|
Leoni AG
OTC:LNNNY
|
DE |
|
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
|
US |
|
Havas NV
F:JP71
|
FR |
|
Vault Minerals Ltd
ASX:VAUDA
|
AU |
|
Ganesh Housing Corp Ltd
BSE:526367
|
IN |
|
IBJ Inc
F:7XR
|
JP |
|
Rogers Communications Inc
F:RCI
|
CA |
|
O
|
Oceaneering International Inc
SWB:OII
|
US |
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
US |
|
D
|
Dermapharm Holding SE
XBER:DMP
|
DE |
|
Sohu.com Ltd
NASDAQ:SOHU
|
CN |
|
R
|
Rogers Communications Inc
XBER:RCIB
|
CA |
|
Lohilo Foods AB (publ)
F:66Q
|
SE |
|
Q
|
QBeyond AG
XMUN:QBY0
|
DE |
|
Opthea Ltd
ASX:OPT
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VERV's stock price target?
Not Available
VERV does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Verve Therapeutics Inc?
Projected CAGR
-18%
The compound annual growth rate for Revenue over the next 3 years is -18%.